Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD for Anxiety
NCT04286594Phase 2Terminated
- Sponsor
- McLean Hospital
- Start
- Feb 2021
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in anxiety disorder, sponsored by McLean Hospital. Started Feb 2021; status: terminated.
02
Drugs
cannabidiol
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT04286594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04286594.